These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 1671419

  • 1. Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.
    Horwell DC, Hughes J, Hunter JC, Pritchard MC, Richardson RS, Roberts E, Woodruff GN.
    J Med Chem; 1991 Jan; 34(1):404-14. PubMed ID: 1671419
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of CCK-B antagonists.
    Horwell DC.
    Neuropeptides; 1991 Jul; 19 Suppl():57-64. PubMed ID: 1881533
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C, Galleyrand JC, Lima-Leite AC, Fulcrand P, Martinez J.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):511-9. PubMed ID: 8750713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O, Mennuni L, Revel L, Colombo S, Makovec F.
    Eur J Pharmacol; 1996 Jun 13; 306(1-3):325-33. PubMed ID: 8813647
    [Abstract] [Full Text] [Related]

  • 12. Second generation "peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.
    Trivedi BK, Padia JK, Holmes A, Rose S, Wright DS, Hinton JP, Pritchard MC, Eden JM, Kneen C, Webdale L, Suman-Chauhan N, Boden P, Singh L, Field MJ, Hill D.
    J Med Chem; 1998 Jan 01; 41(1):38-45. PubMed ID: 9438020
    [Abstract] [Full Text] [Related]

  • 13. Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives.
    Makovec F, Peris W, Revel L, Giovanetti R, Mennuni L, Rovati LC.
    J Med Chem; 1992 Jan 01; 35(1):28-38. PubMed ID: 1732532
    [Abstract] [Full Text] [Related]

  • 14. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.
    Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN.
    Proc Natl Acad Sci U S A; 1990 Sep 01; 87(17):6728-32. PubMed ID: 1975695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Affinity of cholecystokinin receptor antagonists for the gastrin-binding protein.
    Rorison KA, Yang Z, Baldwin GS.
    Eur J Pharmacol; 2000 Jan 24; 388(1):9-15. PubMed ID: 10657541
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K, Lin CW, Kopecka H, Craig R, Wagenaar FL, Bianchi B, Miller T, Witte D, Nadzan AM.
    J Med Chem; 1990 Nov 24; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.